Abstract:AbstractBackgroundAlzheimer’s disease (AD) is characterized by deposition of amyloid‐β (Aβ) plaques, neurofibrillary tangles. Metformin has been reported to decrease Aβ plaque load , reduce spatial memory deficit in APP/PS1 mice and reduce tau phosphorylation in the P301S mutant human tau (P301S) transgenic mouse. However, the effect of metformin on Aβ plaque‐associated tau pathogies remains unclear.MethodFemale 9‐month‐old APPswe/PS1DE9(APP/PS1) mice were used. Mice in the treatment group received 4 mg/ml metformin in the drinking water for 2 months. Brain extract containing tau aggregates isolated from P301S transgenic mouse brain was unilaterally injected into the right hippocampus and overlying cerebral cortex two weeks after the initial administration of metformin. Tau pathology, its effect on Aβ pathology and plaque‐associated microgliosis were assessed by immunohistochemical staining and immunofluorescence analysis 50 days after infusion.ResultWe observed seeded tau aggregates in dystrophic neurites surrounding Aβ plaques(NP tau) throughout the ipsilateral hippocmapus as well as spread to the contralateral hippocmapus in seeded mice using this experimental paradigm. NP tau aggregation was reduced after metformin administration. We found a decrease in the number of microglia around Aβ plaques in hippocampus of seeded mice and an increase of Aβ load in the bilateral cortex and the ipsilateral dentate gyrus of hippocampus in seeded mice. Metformin administration enhanced the activation of microglia around Aβ plaques and attenuates the Aβ load in the seeded mice.ConclusionThese findings indicate that metformin can enhance plaque‐associated microgliosis, attenuate Aβ load and peri‐plaque tau pathologies, making it a potential therapeutic treatment for AD.

Aβ-responsive Metformin-Based Supramolecular Synergistic Nanodrugs for Alzheimer's Disease Via Enhancing Microglial Aβ Clearance.

Multifunctional mesoporous nanoselenium delivery of metformin breaks the vicious cycle of neuroinflammation and ROS, promotes microglia regulation and alleviates Alzheimer's disease

Metformin Carbon Dots Enhance Neurogenesis and Neuroprotection in Alzheimer's Disease: A Potential Nanomedicine Approach

Inhibition of Aβ Aggregation and Tau Phosphorylation with Functionalized Biomimetic Nanoparticles for Synergic Alzheimer’s Disease Therapy

Metformin Treatment Attenuates Tau Seeding in Neuritic Plaques

Co-Assembled Nanoparticles toward Multi-Target Combinational Therapy of Alzheimer's Disease by Making Full Use of Molecular Recognition and Self-Assembly

Inhibition of Aβ Aggregation and Tau Phosphorylation with Functionalized Biomimetic Nanoparticles for Synergic Alzheimer's Disease Therapy

A Novel Targeted and High‐Efficiency Nanosystem for Combinational Therapy for Alzheimer's Disease

Multifunctional Supramolecular Vesicles as Zn<sup>2+</sup>‐Triggered Microglial Modulator Alleviates Alzheimer's Disease

Multifunctional Supramolecular Vesicles as Zn2+‐Triggered Microglial Modulator Alleviates Alzheimer's Disease

Aβ42 and ROS dual-targeted multifunctional nanocomposite for combination therapy of Alzheimer's disease

“Drug‐carrier” Synergy Therapy for Amyloid‐β Clearance and Inhibition of Tau Phosphorylation Via Biomimetic Lipid Nanocomposite Assembly

Nanocomposites Inhibit the Formation, Mitigate the Neurotoxicity, and Facilitate the Removal of Β-Amyloid Aggregates in Alzheimer’s Disease Mice

Ultra-stable Dextran Conjugated Prodrug Micelles for Oxidative Stress and Glycometabolic Abnormality Combination Treatment of Alzheimer's Disease.

Aβ42 and ROS Dual-targeted Multifunctional Nanocomposite for Combination Therapy of Alzheimer’s Disease

Macrophage Membrane-Modified MoS2 Quantum Dots as a Nanodrug for Combined Multi-Targeting of Alzheimer's Disease

Gm1-Modified Lipoprotein-Like Nanoparticle: Multifunctional Nanoplatform for the Combination Therapy of Alzheimer'S Disease

Multifunctional Nanorods Based on Self-Assembly of Biomimetic Apolipoprotein E Peptide for the Treatment of Alzheimer's Disease.

Amyloid-β/Tau Burden and Neuroinflammation Dual-Targeted Nanomedicines Synergistically Restore Memory and Recognition of Alzheimer’s Disease Mice

Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy

Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer’s Disease